Sunstone Life Science Ventures
Sunstone Life Science Ventures is an independent European venture capital firm focused on early-stage life science companies developing novel therapeutics for humans. They invest in opportunities targeting unmet medical needs in commercially attractive markets, prioritizing companies with strong management teams and suitable for M&A exits.
📥 Buy Full VC Dataset
Offices: Copenhagen (Denmark)
Investment Stages: Series A, Series B
Markets: Life science therapeutics
Founded Year: 2007
Investor Type: Venture Capital
Portfolio Companies: F2G, IO Biotech, Minervax, Oxthera, Step Pharma, Synendos, Acarix, Alligator Bioscience, Arcoma, Ascelia, Cantargia, Egalet, Evolva, Follicum, Galecto, Inc., Nuevolution, Orphazyme, Zealand Pharma, Action Pharma, Euro Diagnostica, Forendo Pharma, Jurag Separation, Precisense, Prexton Therapeutics, Rigontec, Santaris Pharma, Symphogen, Zymenex, Vaximm, Stipe Therapeutics
Website: https://sunstone.eu
Team Page: https://sunstone.eu/people/
Portfolio Link: https://sunstone.eu/portfolio/
LinkedIn: https://www.linkedin.com/company/sunstone-life-science-ventures
Crunchbase: https://www.crunchbase.com/organization/sunstone-capital-life-science
Comments
No comments yet. Be the first to comment!